loadpatents
Patent applications and USPTO patent grants for NKT Therapeutics Inc..The latest application filed is for "combination therapy with il-12".
Patent | Date |
---|---|
Humanized antibodies to iNKT Grant 9,932,402 - Truneh , et al. April 3, 2 | 2018-04-03 |
Combination Therapy With Il-12 App 20160022777 - Schaub; Robert ;   et al. | 2016-01-28 |
Combination Therapy App 20150165021 - Mashal; Robert ;   et al. | 2015-06-18 |
HUMANIZED ANTIBODIES TO iNKT App 20130136735 - Truneh; Alemseged ;   et al. | 2013-05-30 |
NCAGE Code | 5BWU0 | NKT THERAPEUTICS INC. |
NCAGE Code | 6UMC9 | NKT THERAPEUTICS INC.!DBA USE CAGE CODE 5BWU0 FOR!CATALOGING |
CAGE Code | 5BWU0 | NKT THERAPEUTICS INC. |
CAGE Code | 6UMC9 | NKT THERAPEUTICS INC. USE CAGE CODE 5BWU0 FOR CATALOGING |
DUNS | 015517455 | NKT Therapeutics Inc. |
SEC | 0001452964 | NKT THERAPEUTICS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.